product summary
Loading...
company name :
Abnova
product type :
antibody
product name :
YAP1 monoclonal antibody (M01), clone 2F12
catalog :
H00010413-M01
quantity :
100 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
2F12
reactivity :
human, mouse, rat
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, immunoprecipitation, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 18
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; mouse; 1:100; loading ...; fig 5a
Korotkevich E, Niwayama R, Courtois A, Friese S, Berger N, Buchholz F, et al. The Apical Domain Is Required and Sufficient for the First Lineage Segregation in the Mouse Embryo. Dev Cell. 2017;40:235-247.e7 pubmed publisher
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
Lee H, Diaz M, Price K, Ozuna J, Zhang S, Sevick Muraca E, et al. Fluid shear stress activates YAP1 to promote cancer cell motility. Nat Commun. 2017;8:14122 pubmed publisher
  • immunohistochemistry - frozen section; mouse; 1:60; loading ...; fig s3a
  • western blot; mouse; 1:500; loading ...; fig 3b
Hirai M, Arita Y, McGlade C, Lee K, Chen J, Evans S. Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest. 2017;127:569-582 pubmed publisher
  • western blot; rat; 1:400; loading ...; fig 3b
  • western blot; human; 1:400; loading ...; fig 10a
Simile M, Latte G, Demartis M, Brozzetti S, Calvisi D, Porcu A, et al. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. Oncotarget. 2016;7:49194-49216 pubmed publisher
  • immunoprecipitation; human; loading ...; fig 5d
Yang S, Zhang L, Purohit V, Shukla S, Chen X, Yu F, et al. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015;6:36019-31 pubmed publisher
  • immunoprecipitation; human; fig 1
Yang S, Zhang L, Chen X, Chen Y, Dong J. Oncoprotein YAP regulates the spindle checkpoint activation in a mitotic phosphorylation-dependent manner through up-regulation of BubR1. J Biol Chem. 2015;290:6191-202 pubmed publisher
  • immunocytochemistry; mouse; 1:100
Shao D, Zhai P, Del Re D, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315 pubmed publisher
Lane B, Heller B, Hollenberg M, Wells C. The RGS-RhoGEFs control the amplitude of YAP1 activation by serum. Sci Rep. 2021;11:2348 pubmed publisher
Bora Singhal N, Mohankumar D, Saha B, Colin C, Lee J, Martin M, et al. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2. Sci Rep. 2020;10:4722 pubmed publisher
Maître J, Turlier H, Illukkumbura R, Eismann B, Niwayama R, Nedelec F, et al. Asymmetric division of contractile domains couples cell positioning and fate specification. Nature. 2016;536:344-348 pubmed publisher
Yang S, Zhang L, Liu M, Chong R, Ding S, Chen Y, et al. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res. 2013;73:6722-33 pubmed publisher
Hirate Y, Cockburn K, Rossant J, Sasaki H. Tead4 is constitutively nuclear, while nuclear vs. cytoplasmic Yap distribution is regulated in preimplantation mouse embryos. Proc Natl Acad Sci U S A. 2012;109:E3389-90; author reply E3391-2 pubmed publisher
Skouloudaki K, Walz G. YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation. PLoS ONE. 2012;7:e35735 pubmed publisher
Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development. 2011;138:3907-14 pubmed publisher
Sekido Y. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation. Pathol Int. 2011;61:331-44 pubmed publisher
Leivonen S, Rokka A, Östling P, Kohonen P, Corthals G, Kallioniemi O, et al. Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact. Mol Cell Proteomics. 2011;10:M110.005322 pubmed publisher
Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71:873-83 pubmed publisher
Lau Y, Murray L, Houshmandi S, Xu Y, Gutmann D, Yu Q. Merlin is a potent inhibitor of glioma growth. Cancer Res. 2008;68:5733-42 pubmed publisher
product information
catalog id :
H00010413-M01
product name :
YAP1 monoclonal antibody (M01), clone 2F12
product description :
Mouse monoclonal antibody raised against a partial recombinant YAP1.
clone name :
2F12
isotype :
IgG2a Kappa
gene name :
YAP1
gene alias :
YAP YAP2 YAP65 YKI
gene description :
Yes-associated protein 1, 65kDa
genbank accession :
NM_006106
immunogen :
YAP1 (NP_006097, 53 a.a. ~ 161 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
immunogen sequence protein sequence :
QIVHVRGDSETDLEALFNAVMNPKTANVPQTVPMRLRKL
PDSFFKPPEPKSHSRQASTDAGTAGALTPQHVRAHSSPA
SLQLGAVSPGTLTPTGVVSGPAATPTAQHLR
protein accession :
NP_006097
storage buffer :
In 1x PBS, pH 7.4
storage instruction :
Store at -20 C or lower. Aliquot to avoid repeated freezing and thawing
quality control testing :
Antibody Reactive Against Recombinant Protein
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human,Mouse
application key :
WB-Tr,WB-Ce,ELISA,WB-Re,IF,IHC-P
size :
100 ug
autodate :
10/10/06
updatetime :
11/15/13 18:29
more info or order :
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com
877-853-6098